Atlas of Genetics and Cytogenetics in Oncology and Haematology

Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

PBRM1 (polybromo 1)

Written2013-03Rafal Pawlowski
Institute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland

(Note : for Links provided by Atlas : click)


Alias_symbol (synonym)BAF180
Other alias
LocusID (NCBI) 55193
Atlas_Id 43697
Location 3p21.1  [Link to chromosome band 3p21]
Location_base_pair Starts at 52545389 and ends at 52685780 bp from pter ( according to hg19-Feb_2009)  [Mapping PBRM1.png]
Local_order The PBRM1 gene is located between the NT5DC2 and GLT8D1 genes on chromosome 3p21.1.
  Location of PBRM1 gene on chromosome 3 p21.1. PBRM1 gene is indicated in red, neighbouring genes in blue. Arrows indicate direction.
Fusion genes
(updated 2017)
Data from Atlas, Mitelman, Cosmic Fusion, Fusion Cancer, TCGA fusion databases with official HUGO symbols (see references in chromosomal bands)
DUSP7 (3p21.2) / PBRM1 (3p21.1)GGPS1 (1q42.3) / PBRM1 (3p21.1)NISCH (3p21.1) / PBRM1 (3p21.1)
PBRM1 (3p21.1) / BAP1 (3p21.1)PBRM1 (3p21.1) / CACNA2D3 (3p21.1)PBRM1 (3p21.1) / CYB561D2 (3p21.31)
PBRM1 (3p21.1) / IGSF11 (3q13.32)PBRM1 (3p21.1) / KYNU (2q22.2)PBRM1 (3p21.1) / NEK4 (3p21.1)
PBRM1 (3p21.1) / TKT (3p21.1)PBRM1 (3p21.1) / TMEM110-MUSTN1 (3p21.1)


  The exon-intron organisation of the PBRM1 gene. Exons are shown as dark blue boxes and broken lines connecting the exons indicate introns. Exon and intron sizes are in scale.
Description PBRM1 gene is located on chromosome 3p21.1 and spans 140566 base pairs on the minus DNA strand.
Transcription 20 transcripts have been annotated for the PBRM1 gene (according to Ensembl as of February 2013), which consists of 30 exons.
Pseudogene PBRM1 pseudogenes are not known.


  Schematic diagram of the PBRM1 (BAF180) protein. BD1-6: bromodomain 1-6; BAH1 and BAH2: bromo-adjacent homology domains 1 and 2; HMG: high mobility group domain.
Description Human PBRM1 gene encodes an 1582 amino acid protein, also referred to as BAF180. Six bromodomains (BD1-6), known to recognize acetylated lysine residues and frequently found in chromatin-associated proteins, constitute the N-terminal half of PBRM1. The C-terminal half of PBRM1 contains two bromo-adjacent homology (BAH) domains (BAH1 and BAH2), present in some proteins involved in transcription regulation. High mobility group (HMG) domain is located close to the C-terminus of PBRM1. HMG domains are found in a number of factors regulating DNA-dependent processes where HMG domains often mediate interactions with DNA.
Expression PBRM1 is ubiquitously expressed during mouse embryonic development (Wang et al., 2004), and has been detected in various human tissues including pancreas, kidney, skeletal muscle, liver, lung, placenta, brain, heart, intestine, ovaries, testis, prostate, thymus and spleen (Xue et al., 2000; Horikawa and Barrett, 2002).
Localisation PBRM1 protein localises to the nucleus of cells (Nicolas and Goodwin, 1996). As a component of the PBAF chromatin-remodelling complex, it associates with chromatin (Thompson, 2009), and has been reported to confer the localisation of PBAF complex to the kinetochores of mitotic chromosomes (Xue et al., 2000).
Function PBRM1/BAF180 functions in the regulation of gene expression as a constituent of the evolutionary-conserved SWI/SNF chromatin remodelling complexes (Euskirchen et al., 2012). Beside BRD7 and BAF200, PBRM1 is one of the unique components of the SWI/SNF-B complex also known as polybromo/BRG1-associated factors (or PBAF), absent in the SWI/SNF-A (BAF) complex (Xue et al., 2000; Brownlee et al., 2012). On that account, and because it contains bromodomains known to mediate binding to acetylated histones, PBRM1 has been postulated to target PBAF complex to specific chromatin sites, therefore providing the functional selectivity for the complex (Xue et al., 2000; Lemon et al., 2001; Brownlee et al., 2012). Although direct evidence for PBRM1 involvement is lacking, SWI/SNF complexes have also been shown to play a role in DNA damage response (Park et al., 2006).
In vivo studies have shown that PBRM1 deletion leads to embryonic lethality in mice, where PBRM1 is required for mammalian cardiac chamber maturation and coronary vessel formation (Wang et al., 2004; Huang et al., 2008).
More recently, PBRM1 has acceded the continuously growing group of SWI/SNF subunits frequently mutated in cancer (Wilson and Roberts, 2011; Shain and Pollack, 2013). PBRM1 mutations are most predominant in renal cell carcinomas detected in over 40% of cases, placing PBRM1 second (after VHL) on the list of most frequently mutated genes in this cancer (Varela et al., 2011; Hakimi et al., 2013; Peña-Llopis et al., 2012; Pawlowski et al., 2013). PBRM1 mutations have also been found in a smaller group of breast and pancreatic cancers (Xia et al., 2008; Shain et al., 2012; Numata et al., 2013). Therefore, PBRM1 is considered a novel tumour suppressor in these cancers.
Homology PBRM1 protein is highly conserved across animal kingdom, from flies and worms though all vertebrates to humans.


Germinal Germinal mutations of PBRM1 have not been reported.
Somatic PBRM1 mutations have been found in a large fraction of clear cell renal cell carcinomas (Varela et al., 2011; Duns et al., 2012; Hakimi et al., 2013), and to a smaller extend also in breast (Xia et al., 2008; Shain and Pollack, 2013) and pancreatic cancers (Numata et al., 2013; Shain and Pollack, 2013). The vast majority of PBRM1 mutations found in renal and breast cancers are truncating (nonsense, frameshift insertions and deletions) (Varela et al., 2011; Hakimi et al., 2013).

Implicated in

Entity Renal cell carcinoma (RCC)
Note PBRM1 mutations and/or loss of protein expression have been reported in a large portion of clear cell subtype of RCC (Varela et al., 2011; Duns et al., 2012; Hakimi et al., 2013; Peña-Llopis et al., 2012; Pawlowski et al., 2013). Therefore, PBRM1 has been postulated to function as a tumour suppressor and the second major RCC cancer gene after VHL. PBRM1 mutations are largely mutually exclusive with BAP1 mutations (Peña-Llopis et al., 2012; Kapur et al., 2013).
Prognosis PBRM1 mutations are more common in patients with advance stages (Hakimi et al., 2013) and loss of PBRM1 protein expression has been associated with advanced tumour stage, low differentiation grade and worse patient outcome (Pawlowski et al., 2013). In another study, no correlation between PBRM1 status and tumour grade was found (Peña-Llopis et al., 2012). Although PBRM1-mutant tumours are associated with better prognosis than BAP1-mutant tumours, tumours mutated for both PBRM1 and BAP1 exhibit the greatest aggressiveness (Kapur et al., 2013).
Entity Breast cancer
Note Truncating mutations have been identified in a minority of breast cancers (Xia et al., 2008). In their study, authors showed inhibition of cell proliferation upon PBRM1 re-introduction into a mutant cell line, thus providing direct evidence for tumour suppressing role of PBRM1 in breast cancer.
Entity Pancreatic cancer
Note Mutations in PBRM1 have been reported in a small fraction of pancreatic cancer samples (Numata et al., 2013).


Cancer and the bromodomains of BAF180.
Brownlee PM, Chambers AL, Oliver AW, Downs JA.
Biochem Soc Trans. 2012 Apr;40(2):364-9. doi: 10.1042/BST20110754. (REVIEW)
PMID 22435813
Targeted exome sequencing in clear cell renal cell carcinoma tumors suggests aberrant chromatin regulation as a crucial step in ccRCC development.
Duns G, Hofstra RM, Sietzema JG, Hollema H, van Duivenbode I, Kuik A, Giezen C, Jan O, Bergsma JJ, Bijnen H, van der Vlies P, van den Berg E, Kok K.
Hum Mutat. 2012 Jul;33(7):1059-62. doi: 10.1002/humu.22090. Epub 2012 Apr 30.
PMID 22461374
SWI/SNF chromatin-remodeling factors: multiscale analyses and diverse functions.
Euskirchen G, Auerbach RK, Snyder M.
J Biol Chem. 2012 Sep 7;287(37):30897-905. doi: 10.1074/jbc.R111.309302. Epub 2012 Sep 5. (REVIEW)
PMID 22952240
Clinical and pathologic impact of select chromatin-modulating tumor suppressors in clear cell renal cell carcinoma.
Hakimi AA, Chen YB, Wren J, Gonen M, Abdel-Wahab O, Heguy A, Liu H, Takeda S, Tickoo SK, Reuter VE, Voss MH, Motzer RJ, Coleman JA, Cheng EH, Russo P, Hsieh JJ.
Eur Urol. 2013 May;63(5):848-54. doi: 10.1016/j.eururo.2012.09.005. Epub 2012 Sep 27.
PMID 23036577
cDNA cloning of the human polybromo-1 gene on chromosome 3p21.
Horikawa I, Barrett JC.
DNA Seq. 2002 Aug;13(4):211-5.
PMID 12487023
Coronary development is regulated by ATP-dependent SWI/SNF chromatin remodeling component BAF180.
Huang X, Gao X, Diaz-Trelles R, Ruiz-Lozano P, Wang Z.
Dev Biol. 2008 Jul 15;319(2):258-66. doi: 10.1016/j.ydbio.2008.04.020. Epub 2008 Apr 24.
PMID 18508041
Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation.
Kapur P, Pena-Llopis S, Christie A, Zhrebker L, Pavia-Jimenez A, Rathmell WK, Xie XJ, Brugarolas J.
Lancet Oncol. 2013 Feb;14(2):159-67. doi: 10.1016/S1470-2045(12)70584-3. Epub 2013 Jan 16.
PMID 23333114
Selectivity of chromatin-remodelling cofactors for ligand-activated transcription.
Lemon B, Inouye C, King DS, Tjian R.
Nature. 2001 Dec 20-27;414(6866):924-8.
PMID 11780067
Molecular cloning of polybromo, a nuclear protein containing multiple domains including five bromodomains, a truncated HMG-box, and two repeats of a novel domain.
Nicolas RH, Goodwin GH.
Gene. 1996 Oct 10;175(1-2):233-40.
PMID 8917104
The clinical significance of SWI/SNF complex in pancreatic cancer.
Numata M, Morinaga S, Watanabe T, Tamagawa H, Yamamoto N, Shiozawa M, Nakamura Y, Kameda Y, Okawa S, Rino Y, Akaike M, Masuda M, Miyagi Y.
Int J Oncol. 2013 Feb;42(2):403-10. doi: 10.3892/ijo.2012.1723. Epub 2012 Nov 30.
PMID 23229642
Mammalian SWI/SNF complexes facilitate DNA double-strand break repair by promoting gamma-H2AX induction.
Park JH, Park EJ, Lee HS, Kim SJ, Hur SK, Imbalzano AN, Kwon J.
EMBO J. 2006 Sep 6;25(17):3986-97. Epub 2006 Aug 24.
PMID 16932743
Loss of PBRM1 expression is associated with renal cell carcinoma progression.
Pawlowski R, Muhl SM, Sulser T, Krek W, Moch H, Schraml P.
Int J Cancer. 2013 Jan 15;132(2):E11-7. doi: 10.1002/ijc.27822. Epub 2012 Oct 3.
PMID 22949125
BAP1 loss defines a new class of renal cell carcinoma.
Pena-Llopis S, Vega-Rubin-de-Celis S, Liao A, Leng N, Pavia-Jimenez A, Wang S, Yamasaki T, Zhrebker L, Sivanand S, Spence P, Kinch L, Hambuch T, Jain S, Lotan Y, Margulis V, Sagalowsky AI, Summerour PB, Kabbani W, Wong SW, Grishin N, Laurent M, Xie XJ, Haudenschild CD, Ross MT, Bentley DR, Kapur P, Brugarolas J.
Nat Genet. 2012 Jun 10;44(7):751-9. doi: 10.1038/ng.2323.
PMID 22683710
Convergent structural alterations define SWItch/Sucrose NonFermentable (SWI/SNF) chromatin remodeler as a central tumor suppressive complex in pancreatic cancer.
Shain AH, Giacomini CP, Matsukuma K, Karikari CA, Bashyam MD, Hidalgo M, Maitra A, Pollack JR.
Proc Natl Acad Sci U S A. 2012 Jan 31;109(5):E252-9. doi: 10.1073/pnas.1114817109. Epub 2012 Jan 10.
PMID 22233809
The spectrum of SWI/SNF mutations, ubiquitous in human cancers.
Shain AH, Pollack JR.
PLoS One. 2013;8(1):e55119. doi: 10.1371/journal.pone.0055119. Epub 2013 Jan 23.
PMID 23355908
Polybromo-1: the chromatin targeting subunit of the PBAF complex.
Thompson M.
Biochimie. 2009 Mar;91(3):309-19. doi: 10.1016/j.biochi.2008.10.019. Epub 2008 Dec 3. (REVIEW)
PMID 19084573
Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma.
Varela I, Tarpey P, Raine K, Huang D, Ong CK, Stephens P, Davies H, Jones D, Lin ML, Teague J, Bignell G, Butler A, Cho J, Dalgliesh GL, Galappaththige D, Greenman C, Hardy C, Jia M, Latimer C, Lau KW, Marshall J, McLaren S, Menzies A, Mudie L, Stebbings L, Largaespada DA, Wessels LF, Richard S, Kahnoski RJ, Anema J, Tuveson DA, Perez-Mancera PA, Mustonen V, Fischer A, Adams DJ, Rust A, Chan-on W, Subimerb C, Dykema K, Furge K, Campbell PJ, Teh BT, Stratton MR, Futreal PA.
Nature. 2011 Jan 27;469(7331):539-42. doi: 10.1038/nature09639. Epub 2011 Jan 19.
PMID 21248752
Polybromo protein BAF180 functions in mammalian cardiac chamber maturation.
Wang Z, Zhai W, Richardson JA, Olson EN, Meneses JJ, Firpo MT, Kang C, Skarnes WC, Tjian R.
Genes Dev. 2004 Dec 15;18(24):3106-16.
PMID 15601824
SWI/SNF nucleosome remodellers and cancer.
Wilson BG, Roberts CW.
Nat Rev Cancer. 2011 Jun 9;11(7):481-92. doi: 10.1038/nrc3068. (REVIEW)
PMID 21654818
BAF180 is a critical regulator of p21 induction and a tumor suppressor mutated in breast cancer.
Xia W, Nagase S, Montia AG, Kalachikov SM, Keniry M, Su T, Memeo L, Hibshoosh H, Parsons R.
Cancer Res. 2008 Mar 15;68(6):1667-74. doi: 10.1158/0008-5472.CAN-07-5276.
PMID 18339845
The human SWI/SNF-B chromatin-remodeling complex is related to yeast rsc and localizes at kinetochores of mitotic chromosomes.
Xue Y, Canman JC, Lee CS, Nie Z, Yang D, Moreno GT, Young MK, Salmon ED, Wang W.
Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13015-20.
PMID 11078522


This paper should be referenced as such :
Pawlowski, R
PBRM1 (polybromo 1)
Atlas Genet Cytogenet Oncol Haematol. 2013;17(9):605-608.
Free journal version : [ pdf ]   [ DOI ]
On line version :

Other Solid tumors implicated (Data extracted from papers in the Atlas) [ 10 ]
  t(2;3)(q22;p21) PBRM1/KYNU
t(3;3)(p21;p21) NISCH/PBRM1
t(3;3)(p21;p21) DUSP7/PBRM1
t(3;3)(p21;p21) PBRM1/CACNA2D3
t(3;3)(p21;p21) PBRM1/TKT
t(3;3)(p21;p21) PBRM1/TMEM110-MUSTN1
t(3;3)(p21;p21) PBRM1/BAP1
t(3;3)(p21;p21) PBRM1/CYB561D2
t(3;3)(p21;p21) PBRM1/NEK4
t(3;3)(p21;q13) PBRM1/IGSF11

External links

HGNC (Hugo)PBRM1   30064
Entrez_Gene (NCBI)PBRM1  55193  polybromo 1
AliasesBAF180; PB1
GeneCards (Weizmann)PBRM1
Ensembl hg19 (Hinxton)ENSG00000163939 [Gene_View]
Ensembl hg38 (Hinxton)ENSG00000163939 [Gene_View]  chr3:52545389-52685780 [Contig_View]  PBRM1 [Vega]
ICGC DataPortalENSG00000163939
TCGA cBioPortalPBRM1
Genatlas (Paris)PBRM1
SOURCE (Princeton)PBRM1
Genetics Home Reference (NIH)PBRM1
Genomic and cartography
GoldenPath hg38 (UCSC)PBRM1  -     chr3:52545389-52685780 -  3p21.1   [Description]    (hg38-Dec_2013)
GoldenPath hg19 (UCSC)PBRM1  -     3p21.1   [Description]    (hg19-Feb_2009)
EnsemblPBRM1 - 3p21.1 [CytoView hg19]  PBRM1 - 3p21.1 [CytoView hg38]
Mapping of homologs : NCBIPBRM1 [Mapview hg19]  PBRM1 [Mapview hg38]
Gene and transcription
Genbank (Entrez)AA047886 AA724453 AF177387 AF197569 AF225870
RefSeq transcript (Entrez)NM_001350074 NM_001350075 NM_001350076 NM_001350077 NM_001350078 NM_001350079 NM_018165 NM_018313 NM_181041 NM_181042
RefSeq genomic (Entrez)
Consensus coding sequences : CCDS (NCBI)PBRM1
Cluster EST : UnigeneHs.734413 [ NCBI ]
CGAP (NCI)Hs.734413
Alternative Splicing GalleryENSG00000163939
Gene ExpressionPBRM1 [ NCBI-GEO ]   PBRM1 [ EBI - ARRAY_EXPRESS ]   PBRM1 [ SEEK ]   PBRM1 [ MEM ]
Gene Expression Viewer (FireBrowse)PBRM1 [ Firebrowse - Broad ]
SOURCE (Princeton)Expression in : [Datasets]   [Normal Tissue Atlas]  [carcinoma Classsification]  [NCI60]
GenevestigatorExpression in : [tissues]  [cell-lines]  [cancer]  [perturbations]  
BioGPS (Tissue expression)55193
GTEX Portal (Tissue expression)PBRM1
Human Protein AtlasENSG00000163939-PBRM1 [pathology]   [cell]   [tissue]
Protein : pattern, domain, 3D structure
UniProt/SwissProtQ86U86   [function]  [subcellular_location]  [family_and_domains]  [pathology_and_biotech]  [ptm_processing]  [expression]  [interaction]
NextProtQ86U86  [Sequence]  [Exons]  [Medical]  [Publications]
With graphics : InterProQ86U86
Splice isoforms : SwissVarQ86U86
Domaine pattern : Prosite (Expaxy)BAH (PS51038)    BROMODOMAIN_1 (PS00633)    BROMODOMAIN_2 (PS50014)    HMG_BOX_2 (PS50118)   
Domains : Interpro (EBI)BAH_dom    Bromodomain    Bromodomain_CS    HMG_box_dom   
Domain families : Pfam (Sanger)BAH (PF01426)    Bromodomain (PF00439)    HMG_box (PF00505)   
Domain families : Pfam (NCBI)pfam01426    pfam00439    pfam00505   
Domain families : Smart (EMBL)BAH (SM00439)  BROMO (SM00297)  HMG (SM00398)  
Conserved Domain (NCBI)PBRM1
DMDM Disease mutations55193
Blocks (Seattle)PBRM1
PDB (SRS)2KTB    3G0J    3HMF    3IU5    3IU6    3K2J    3LJW    3MB4    3TLP    4Q0N    4Q0O    4Y03    5E7D    5FH6    5FH7    5FH8    5HRV    5HRW    5HRX    5II1    5II2    5IID   
PDB (PDBSum)2KTB    3G0J    3HMF    3IU5    3IU6    3K2J    3LJW    3MB4    3TLP    4Q0N    4Q0O    4Y03    5E7D    5FH6    5FH7    5FH8    5HRV    5HRW    5HRX    5II1    5II2    5IID   
PDB (IMB)2KTB    3G0J    3HMF    3IU5    3IU6    3K2J    3LJW    3MB4    3TLP    4Q0N    4Q0O    4Y03    5E7D    5FH6    5FH7    5FH8    5HRV    5HRW    5HRX    5II1    5II2    5IID   
PDB (RSDB)2KTB    3G0J    3HMF    3IU5    3IU6    3K2J    3LJW    3MB4    3TLP    4Q0N    4Q0O    4Y03    5E7D    5FH6    5FH7    5FH8    5HRV    5HRW    5HRX    5II1    5II2    5IID   
Structural Biology KnowledgeBase2KTB    3G0J    3HMF    3IU5    3IU6    3K2J    3LJW    3MB4    3TLP    4Q0N    4Q0O    4Y03    5E7D    5FH6    5FH7    5FH8    5HRV    5HRW    5HRX    5II1    5II2    5IID   
SCOP (Structural Classification of Proteins)2KTB    3G0J    3HMF    3IU5    3IU6    3K2J    3LJW    3MB4    3TLP    4Q0N    4Q0O    4Y03    5E7D    5FH6    5FH7    5FH8    5HRV    5HRW    5HRX    5II1    5II2    5IID   
CATH (Classification of proteins structures)2KTB    3G0J    3HMF    3IU5    3IU6    3K2J    3LJW    3MB4    3TLP    4Q0N    4Q0O    4Y03    5E7D    5FH6    5FH7    5FH8    5HRV    5HRW    5HRX    5II1    5II2    5IID   
Human Protein Atlas [tissue]ENSG00000163939-PBRM1 [tissue]
Peptide AtlasQ86U86
IPIIPI00384176   IPI00301041   IPI00334894   IPI00640304   IPI00023097   IPI00398781   IPI00873041   IPI00910435   IPI00909142   IPI00451426   IPI00001787   IPI00917738   IPI00917187   IPI00917316   IPI00916357   IPI00917875   IPI00918010   IPI00917348   IPI00916875   
Protein Interaction databases
IntAct (EBI)Q86U86
Ontologies - Pathways
Ontology : AmiGOnuclear chromosome  mitotic cell cycle  DNA binding  chromatin binding  protein binding  nucleoplasm  chromatin remodeling  transcription, DNA-templated  regulation of transcription, DNA-templated  negative regulation of cell proliferation  covalent chromatin modification  RSC-type complex  
Ontology : EGO-EBInuclear chromosome  mitotic cell cycle  DNA binding  chromatin binding  protein binding  nucleoplasm  chromatin remodeling  transcription, DNA-templated  regulation of transcription, DNA-templated  negative regulation of cell proliferation  covalent chromatin modification  RSC-type complex  
REACTOMEQ86U86 [protein]
REACTOME PathwaysR-HSA-3214858 [pathway]   
NDEx NetworkPBRM1
Atlas of Cancer Signalling NetworkPBRM1
Wikipedia pathwaysPBRM1
Orthology - Evolution
GeneTree (enSembl)ENSG00000163939
Phylogenetic Trees/Animal Genes : TreeFamPBRM1
Homologs : HomoloGenePBRM1
Homology/Alignments : Family Browser (UCSC)PBRM1
Gene fusions - Rearrangements
Fusion : MitelmanDUSP7/PBRM1 [3p21.2/3p21.1]  [t(3;3)(p21;p21)]  
Fusion : MitelmanNISCH/PBRM1 [3p21.1/3p21.1]  [t(3;3)(p21;p21)]  
Fusion : MitelmanPBRM1/CACNA2D3 [3p21.1/3p21.1]  [t(3;3)(p21;p21)]  
Fusion : MitelmanPBRM1/IGSF11 [3p21.1/3q13.32]  [t(3;3)(p21;q13)]  
Fusion : MitelmanPBRM1/KYNU [3p21.1/2q22.2]  [t(2;3)(q22;p21)]  
Fusion : MitelmanPBRM1/NEK4 [3p21.1/3p21.1]  [t(3;3)(p21;p21)]  
Fusion : MitelmanPBRM1/TKT [3p21.1/3p21.1]  [t(3;3)(p21;p21)]  
Fusion : MitelmanPBRM1/TMEM110-MUSTN1 [3p21.1/3p21.1]  [t(3;3)(p21;p21)]  
Fusion: TCGA_MDACCDUSP7 3p21.2 PBRM1 3p21.1 BRCA
Fusion: TCGA_MDACCNISCH 3p21.1 PBRM1 3p21.1 BLCA
Fusion: TCGA_MDACCPBRM1 3p21.1 CACNA2D3 3p21.1 BRCA
Fusion: TCGA_MDACCPBRM1 3p21.1 IGSF11 3q13.32 LUAD
Fusion: TCGA_MDACCPBRM1 3p21.1 KYNU 2q22.2 LGG
Fusion: TCGA_MDACCPBRM1 3p21.1 NEK4 3p21.1 SKCM
Fusion: TCGA_MDACCPBRM1 3p21.1 TKT 3p21.1 BRCA
Fusion: TCGA_MDACCPBRM1 3p21.1 TMEM110-MUSTN1 3p21.1 LUAD
Fusion PortalDUSP7 3p21.2 PBRM1 3p21.1 BRCA
Fusion PortalNISCH 3p21.1 PBRM1 3p21.1 BLCA
Fusion PortalPBRM1 3p21.1 CACNA2D3 3p21.1 BRCA
Fusion PortalPBRM1 3p21.1 IGSF11 3q13.32 LUAD
Fusion PortalPBRM1 3p21.1 KYNU 2q22.2 LGG
Fusion PortalPBRM1 3p21.1 NEK4 3p21.1 SKCM
Fusion PortalPBRM1 3p21.1 TKT 3p21.1 BRCA
Fusion PortalPBRM1 3p21.1 TMEM110-MUSTN1 3p21.1 LUAD
Fusion : QuiverPBRM1
Polymorphisms : SNP and Copy number variants
NCBI Variation ViewerPBRM1 [hg38]
dbSNP Single Nucleotide Polymorphism (NCBI)PBRM1
Exome Variant ServerPBRM1
ExAC (Exome Aggregation Consortium)ENSG00000163939
GNOMAD BrowserENSG00000163939
Genetic variants : HAPMAP55193
Genomic Variants (DGV)PBRM1 [DGVbeta]
DECIPHERPBRM1 [patients]   [syndromes]   [variants]   [genes]  
CONAN: Copy Number AnalysisPBRM1 
ICGC Data PortalPBRM1 
TCGA Data PortalPBRM1 
Broad Tumor PortalPBRM1
OASIS PortalPBRM1 [ Somatic mutations - Copy number]
Cancer Gene: CensusPBRM1 
Somatic Mutations in Cancer : COSMICPBRM1  [overview]  [genome browser]  [tissue]  [distribution]  
Mutations and Diseases : HGMDPBRM1
intOGen PortalPBRM1
LOVD (Leiden Open Variation Database)Whole genome datasets
LOVD (Leiden Open Variation Database)LOVD - Leiden Open Variation Database
LOVD (Leiden Open Variation Database)LOVD 3.0 shared installation
LOVD (Leiden Open Variation Database)LOVD - Leiden Open Variation Database
BioMutasearch PBRM1
DgiDB (Drug Gene Interaction Database)PBRM1
DoCM (Curated mutations)PBRM1 (select the gene name)
CIViC (Clinical Interpretations of Variants in Cancer)PBRM1 (select a term)
NCG5 (London)PBRM1
Cancer3DPBRM1(select the gene name)
Impact of mutations[PolyPhen2] [SIFT Human Coding SNP] [Buck Institute : MutDB] [Mutation Assessor] [Mutanalyser]
Genetic Testing Registry PBRM1
NextProtQ86U86 [Medical]
Target ValidationPBRM1
Huge Navigator PBRM1 [HugePedia]
snp3D : Map Gene to Disease55193
BioCentury BCIQPBRM1
Clinical trials, drugs, therapy
Chemical/Protein Interactions : CTD55193
Chemical/Pharm GKB GenePA162398846
Clinical trialPBRM1
canSAR (ICR)PBRM1 (select the gene name)
Other database
PubMed95 Pubmed reference(s) in Entrez
GeneRIFsGene References Into Functions (Entrez)
REVIEW articlesautomatic search in PubMed
Last year publicationsautomatic search in PubMed

Search in all EBI   NCBI

© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Wed Feb 28 14:01:40 CET 2018

Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

For comments and suggestions or contributions, please contact us